Theratechnologies Announces Completion of Acquisition by Future Pak. Click here to learn more.

Theratechnologies Announces Completion of Acquisition by Future Pak. Click here to learn more.

Theratechnologies Announces Completion of Acquisition by Future Pak.
Click here
to learn more.

Health
innovation that
matters

Theratechnologies is a biopharmaceutical company focused on the development and commercialization of innovative therapies.

We currently market prescription products for people with HIV in the United States.

Communiqués de presse et annonces de la société

Dernières nouvelles

Pipeline & Medicines

Product Pipeline & Portfolio

Theratechnologies develops and commercializes innovative therapies. The Company currently commercializes two products in the field of HIV. Trogarzo® and EGRIFTA SV®/WR™ are approved in the United States.

Preclinical

Phase 1

Phase 2

Phase 3

Approved

Marketed

Responsive Drug Pipeline Chart
HIV
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Marketed

Search

Theratechnologies